All About Alzheimer's Caring Conversations

“Take your meds and keep up with your friends.”

For the first time, drugs targeting amyloid plaques have moved beyond trials and into real world use. Treatments like Kisunla and Leqembi, approved in 2023 and 2024, have helped validate the long debated amyloid theory.

When “Just Stress” Wasn’t the Answer: Melissa and Kevin’s Story

10 alarming statistics about dementia care in the UK

Living with Dementia: Mike’s Experience

Living With Dementia – A Personal Story

Learn why setting up a Power of Attorney early is crucial for dementia care. We explain POAs, court orders, and how to protect your loved one’s future.

Learn Professor Gill Livingston’s 10 practical tips to reduce dementia risk — small daily habits that make a big difference for brain health.

Chris Long was the first patient at MUSC Health to receive the Alzheimer’s drug, Leqembi. Eighteen months on, he’s still golfing, spending time with friends, and feeling hopeful about the future. In this episode, Harvey shares Chris’s story, what his wife and doctors have observed, and the important facts to know if you’re considering this new treatment.

In this episode of All About Alzheimer’s, we explore how artificial intelligence could help answer one of the toughest questions following a dementia diagnosis: what happens next? Inspired by insights from Dr Timothy Rittman and Professor Zoe Kourtzi, we unpack how AI is being tested to not only diagnose Alzheimer’s but potentially predict how quickly the disease will progress. We look at the parallels between breast cancer screening and brain imaging, and how emerging AI tools could transform

Would you want to know if you were at risk of developing Alzheimer’s — even before symptoms began? In this episode of All About Alzheimer’s, we explore the growing shift in public attitudes towards early testing, diagnosis, and treatment of Alzheimer’s. Backed by compelling data from the Alzheimer’s Association, we discuss why more people than ever are choosing to find out early — and what that means for planning, treatment, and peace of mind. We cover: Why 4 out of 5 people want to be tested

In this episode of Let’s Talk Money, we uncover the often-overlooked financial warning signs and long-term costs of Alzheimer’s and dementia care. From missed bill payments to sudden risky investments, the financial impact can begin years before a diagnosis is even made. We discuss groundbreaking research, the three financial stages of the disease, and offer practical steps you can take today to protect your loved one’s finances and your peace of mind. Whether you’re a caregiver, a family memb

Thanks to earlier diagnosis, more people are being faced with a difficult and emotional question: When should I tell others I have Alzheimer’s? In this episode of All About Alzheimers, we talk through the timing, the conversations, and the emotional impact of sharing your diagnosis, with family, friends, employers, and beyond. We also offer guidance for those hearing this news from someone they care about. 🟣 For more support, resources, and weekly guidance, visit allaboutalzheimers.ai.